表紙
市場調查報告書
商品編碼
1046468

孤立性纖維性腫瘤治療的全球市場 (各治療法 (手術,放射治療,佐劑化療),各終端用戶 (門診病人手術中心,醫院,其他)) 產業分析,市場規模、佔有率、成長、趨勢、預測 (2021年∼2031年)

Solitary Fibrous Tumor Treatment Market (Treatment: Surgery, Radiation Therapy, & Adjuvant Chemotherapy; & End-user: Ambulatory Surgical Centers, Hospitals, & Others) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2021-2031

出版日期: | 出版商: Transparency Market Research | 英文 126 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球孤立性纖維性腫瘤治療的市場相關分析,市場基本結構和主要的影響要素,市場規模、年複合成長率趨勢預測 (2017年∼2031年),各治療法、各終端用戶及各地區的詳細趨勢,競爭環境 (市場佔有率結構),主要企業簡介等調查。

目錄

第1章 序論

第2章 假設調查手法

第3章 摘要整理:全球孤立性纖維性腫瘤治療市場

第4章 市場概要

  • 簡介和概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 全球孤立性纖維性腫瘤治療市場分析與預測 (2017年∼2031年)

第5章 市場預測

  • 開發平台分析
  • 新型冠狀病毒感染疾病 (COVID-19) 的影響分析
  • 患者人口資料 (2018年∼2020年)

第6章 全球孤立性纖維性腫瘤治療市場分析與預測:各治療法

  • 簡介和定義
  • 市場預測:各治療法 (金額,2017年∼2031年)
    • 手術
    • 放射治療
    • 佐劑化療
  • 市場魅力分析:各治療法

第7章 全球孤立性纖維性腫瘤治療市場分析與預測:各終端用戶

  • 簡介和定義
  • 市場預測:各終端用戶 (金額,2017年∼2031年)
    • 門診病人手術中心
    • 醫院
    • 其他
  • 市場魅力分析:各終端用戶

第8章 全球孤立性纖維性腫瘤治療市場分析與預測:各地區

  • 主要的分析結果
  • 市場預測:各地區 (金額)
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場魅力分析:各地區

第9章 北美的孤立性纖維性腫瘤治療市場分析與預測

  • 簡介
  • 市場預測:各治療法 (金額,2017年∼2031年)
  • 市場預測:各終端用戶 (金額,2017年∼2031年)
  • 市場預測:各國 (金額,2017年∼2031年)
  • 市場魅力分析

第10章 歐洲的孤立性纖維性腫瘤治療市場分析與預測

第11章 亞太地區的孤立性纖維性腫瘤治療市場分析與預測

第12章 南美的孤立性纖維性腫瘤治療市場分析與預測

第13章 中東、非洲的孤立性纖維性腫瘤治療市場分析與預測

目錄
Product Code: TMRGL37022

Solitary Fibrous Tumor Treatment Market - Scope of Report

TMR's report on the global solitary fibrous tumor treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the global solitary fibrous tumor treatment market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global solitary fibrous tumor treatment market from 2021 to 2031.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key industry leaders and opinion makers. Secondary research involved referring to key players' literature, annual reports, press releases, and relevant documents to understand the global solitary fibrous tumor treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global solitary fibrous tumor treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global solitary fibrous tumor treatment market. These serve as valuable tools for existing market players as well as entities interested in participating in the global solitary fibrous tumor treatment market.

The report also delves into the competitive landscape of the global solitary fibrous tumor treatment market. Key players operating in the global solitary fibrous tumor treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global solitary fibrous tumor treatment market that have been profiled in this report.

Key Questions Answered in Solitary Fibrous Tumor Treatment Market Report

What is the sales/revenue generated by treatment providers across all regions during the forecast period?

What are the opportunities in the global solitary fibrous tumor treatment market?

What are the major drivers, restraints, opportunities, and threats in the global market?

Which region is set to expand at the fastest CAGR during the forecast period?

Which application segment is expected to generate the highest revenue globally in 2031?

What are the market positions of different companies operating in the global market?

Solitary Fibrous Tumor Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global solitary fibrous tumor treatment market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of treatments.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global solitary fibrous tumor treatment market in terms of treatment, end-user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global solitary fibrous tumor treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Solitary Fibrous Tumor Treatment Market

4. Market Overview

  • 4.1. Introduction & Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
  • 4.3. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, 2017-2031

5. Market Outlook

  • 5.1. Pipeline Analysis
  • 5.2. COVID-19 Impact Analysis
  • 5.3. Patients Population Data, 2018-2020

6. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, by Treatment

  • 6.1. Introduction & Definition
  • 6.2. Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
    • 6.2.1. Surgery
    • 6.2.2. Radiation Therapy
    • 6.2.3. Adjuvant Chemotherapy
  • 6.3. Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by Treatment

7. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
    • 7.2.1. Ambulatory Surgical Centers
    • 7.2.2. Hospitals
    • 7.2.3. Others
  • 7.3. Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by End-user

8. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Global Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by Region

9. North America Solitary Fibrous Tumor Treatment Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. North America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
    • 9.2.1. Surgery
    • 9.2.2. Radiation Therapy
    • 9.2.3. Adjuvant Chemotherapy
  • 9.3. North America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
    • 9.3.1. Ambulatory Surgical Centers
    • 9.3.2. Hospitals
    • 9.3.3. Others
  • 9.4. North America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. North America Solitary Fibrous Tumor Market Attractiveness Analysis
    • 9.5.1. By Treatment
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Solitary Fibrous Tumor Treatment Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Europe Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
    • 10.2.1. Surgery
    • 10.2.2. Radiation Therapy
    • 10.2.3. Adjuvant Chemotherapy
  • 10.3. Europe Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by End-user, 2017-2031
    • 10.3.1. Ambulatory Surgical Centers
    • 10.3.2. Hospitals
    • 10.3.3. Others
  • 10.4. Europe Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Europe Solitary Fibrous Tumor Treatment Market Attractiveness Analysis
    • 10.5.1. By Treatment
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Solitary Fibrous Tumor Treatment Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Asia Pacific Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
    • 11.2.1. Surgery
    • 11.2.2. Radiation Therapy
    • 11.2.3. Adjuvant Chemotherapy
  • 11.3. Asia Pacific Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
    • 11.3.1. Ambulatory Surgical Centers
    • 11.3.2. Hospitals
    • 11.3.3. Others
  • 11.4. Asia Pacific Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Asia Pacific Solitary Fibrous Tumor Market Attractiveness Analysis
    • 11.5.1. By Treatment
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Solitary Fibrous Tumor Treatment Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Latin America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
    • 12.2.1. Surgery
    • 12.2.2. Radiation Therapy
    • 12.2.3. Adjuvant Chemotherapy
  • 12.3. Latin America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
    • 12.3.1. Ambulatory Surgical Centers
    • 12.3.2. Hospitals
    • 12.3.3. Others
  • 12.4. Latin America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Latin America Solitary Fibrous Tumor Market Attractiveness Analysis
    • 12.5.1. By Treatment
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Solitary Fibrous Tumor Treatment Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Middle East & Africa Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
    • 13.2.1. Surgery
    • 13.2.2. Radiation Therapy
    • 13.2.3. Adjuvant Chemotherapy
  • 13.3. Middle East & Africa Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by End-user, 2017-2031
    • 13.3.1. Ambulatory Surgical Centers
    • 13.3.2. Hospitals
    • 13.3.3. Others
  • 13.4. Middle East & Africa Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Middle East & Africa Solitary Fibrous Tumor Market Attractiveness Analysis
    • 13.5.1. By Treatment
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region
    • 13.5.4. Competition Landscape
  • 13.6. Competition Landscape
  • 13.7. Company Profiles
    • 13.7.1. Pfizer, Inc.
      • 13.7.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.7.1.2. Growth Strategies
      • 13.7.1.3. SWOT Analysis
    • 13.7.2. F. Hoffmann-La Roche Ltd.
      • 13.7.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.7.2.2. Growth Strategies
      • 13.7.2.3. SWOT Analysis
    • 13.7.3. Eli Lilly and Company
      • 13.7.3.1. Company Overview (HQ, Business Segments)
      • 13.7.3.2. Growth Strategies
      • 13.7.3.3. SWOT Analysis
    • 13.7.4. Bayer AG
      • 13.7.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.7.4.2. Growth Strategies
      • 13.7.4.3. SWOT Analysis
    • 13.7.5. Novartis AG
      • 13.7.5.1. Company Overview (HQ, Business Segments)
      • 13.7.5.2. Growth Strategies
      • 13.7.5.3. SWOT Analysis

List of Tables

  • Table 01: Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 02: Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 05: North America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: North America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 07: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 08: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 10: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 11: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 13: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 15: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 18: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 02: Global Solitary Fibrous Tumor Treatment Market Value Share, by Region, 2020
  • Figure 03: Global Solitary Fibrous Tumor Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 04: Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 05: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Surgery, 2017-2031
  • Figure 06: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Radiation Therapy, 2017-2031
  • Figure 07: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Adjuvant Chemotherapy, 2017-2031
  • Figure 08: Global Solitary Fibrous Tumor Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 09: Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 10: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 11: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Ambulatory Surgery Centers, 2017-2031
  • Figure 12: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 13: Global Solitary Fibrous Tumor Treatment Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 14: Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 15: North America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 16: North America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Country, 2020 and 2031
  • Figure 17: North America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Country, 2021-2031
  • Figure 18: North America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 19: North America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 20: North America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 21: North America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 22: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 24: Europe Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 25: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 26: Europe Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 27: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 28: Europe Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 29: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 31: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 32: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 33: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 34: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 35: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 36: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 37: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 38: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 39: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 40: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 41: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 42: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 43: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 44: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 45: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 46: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 47: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 48: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 49: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by End-user, 2021-2031